From the Q3 webcast AS puts the future goals & time frame into...

From the Q3 webcast AS puts the future goals & time frame into perspective for me. At the moment it's just a slow churn with much happening.

"Let me be clear when I say that our primary goal for the Unifill syringe at present is to get as many drugs onto stability studies as possible. Pharmaceutical companies do not enter into stability studies lightly. It is fair to expect that drugs that go onto stability studies with the Unifill syringe will ultimately lead to the signing of long-term commercial supply agreements.

We expect that pharmaceutical companies should begin to sign long-term commercial supply agreements before they begin to build up their inventory of the product during 2012 in preparation for the commercial launch or relaunch of their drugs. It is possible that supply agreements may be signed earlier within therapeutic drug classes where several pharmaceutical companies are competing against each other, and one of them wants to obtain special marketing rights to the Unifill syringe."

"In summary, we believe that we are now poised to commence initial sales of the Unifill syringe in July 2011. Discussions with many pharmaceutical companies continue to accelerate. Indeed, the excitement around the Unifill syringe is now extending well beyond Unilife and into the headquarters of many of our target pharmaceutical customers."

All good, nothing to whinge about there!
Happy holding all.
:-)